 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
Breisacher Str. 117 79106 Freiburg
Germany
|
|
Portrait ProQinase GmbH provides an Integrated Protein Kinase Technology Platform for preclinical drug development of protein kinase inhibitors: More than 150 highly active recombinant kinases are offered for sale and more than 220 kinases are available for in vitro testing services (HTS, selectivity profiling and IC50 determination etc.). Cellular and in vivo test systems including orthotopic tumor and angiogenesis models allow further testing of lead compounds. A Clinical biomarker analysis service supports the evaluation of clinical trials.
Industrial Sectors
- Custom Manufacturing
- Pharmacy
|
- Medicine/Pharmacy
- Biotechnology
|
|
Products
-
drug development
-
contract research
-
CRO
-
angiogenesis model
-
orthotopic model
-
in vivo
-
tumor model
-
animal model
-
angiogenesis
-
angiogenic
-
in vivo angiogenesis
-
angiogenesis assay
-
Xenograft model
-
in vivo model
|
-
kinase supplier
-
serine kinase
-
cellular assays
-
cell-based assays
-
phosphorylation assay
-
in vivo contract research
-
kinases
-
in vitro kinase assay
-
clinical biomarker
-
biomarker assay
-
Clinical trials
-
Biomarker
-
plasma biomarker
|
-
protein kinase
-
tyrosine Kinase
-
kinase
-
recombinant kinase
-
kinase assay
-
IC50 determination
-
High Throughput Screening
-
HTS
-
IC50
-
selectivity profiling
-
compound profiling
-
in vitro testing
-
kinase profiling
|
Additional information
 ProQinase GmbH Freiburg, Germany
News
|
|
|
|
|
|